|
1
|
Cohen SM and Ito N: A critical review of
the toxicological effects of carrageenan and processed eucheuma
seaweed on the gastrointestinal tract. Crit Rev Toxicol.
32:413–444. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nicklin S and Miller K: Intestinal uptake
and immunological effects of carrageenan - current concepts. Food
Addit Contam. 6:425–436. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tobacman JK: Review of harmful
gastrointestinal effects of carrageenan in animal experiments.
Environ Health Perspect. 109:983–994. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Grieg JB: Carrageenan (addendum). Safety
evaluation of certain food additives. (WHO Food Additives Series
42, no. 934). World Health Organization; Geneva: 1999
|
|
5
|
Joint FAO/WHO Expert Committee on Food
Additives (JECFA). Evaluation of certain food additives. (WHO
Technical Report Series 891). World Health Organization; Geneva:
2000
|
|
6
|
JECFA. Evaluation of certain food
additives specifications. Addendum 9. Joint FAO/WHO expert
committee on food additives. (WHO Technical Report series. No.
891). 2001
|
|
7
|
Scientific Committee on Food (SCF).
Opinion of the scientific committee on food on carrageenan.
European Commission; Brussels: 2003
|
|
8
|
Benford DJ, Harrison RA, Strobel S,
Schlatter J and Verger P: Carrageenan and processed Eucheuma
seaweed (addendum). Safety evaluation of certain food additives and
contaminants. (WHO Food Additives Series 59). World Health
Organization; Geneva: pp. 65–86. 2008
|
|
9
|
Watson DB: Public health and carrageenan
regulation: a review and analysis. J Appl Phycol. 20:505–513. 2007.
View Article : Google Scholar
|
|
10
|
Weiner ML, Nuber D, Blakemore WR, Harriman
JF and Cohen SM: A 90-day dietary study on kappa carrageenan with
emphasis on the gastrointestinal tract. Food Chem Toxicol.
45:98–106. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Simpson S, Ash C, Pennisi E and Travis J:
The gut: inside out. Science. 307:18952005. View Article : Google Scholar
|
|
12
|
Cheroutre H: IELs: enforcing law and order
in the court of the intestinal epithelium. Immunol Rev.
206:114–131. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rodriguez P, Heyman M, Candalh C, Blaton
MA and Bouchaud C: Tumour necrosis factor-alpha induces
morphological and functional alterations of intestinal HT29 cl.19A
cell monolayers. Cytokine. 7:441–448. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shanahan F: Inflammatory bowel disease:
immunodiagnostics, immunotherapeutics, and ecotherapeutics.
Gastroenterology. 120:622–635. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mosmann T: Rapid colorimetric assay for
cellular growth and survival: application to proliferation and
cytotoxicity assays. J Immunol Methods. 65:55–63. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Satsu H, Ishimoto Y, Nakano T, Mochizuki
T, Iwanaga T and Shimizu M: Induction by activated macrophage-like
THP-1 cells of apoptotic and necrotic cell death in intestinal
epithelial Caco-2 monolayers via tumor necrosis factor-alpha. Exp
Cell Res. 312:3909–3919. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pimentel-Muiños FX and Seed B: Regulated
commitment of TNF receptor signaling: a molecular switch for death
or activation. Immunity. 11:783–793. 1999.PubMed/NCBI
|
|
18
|
Borthakur A, Bhattacharyya S, Dudeja PK
and Tobacman JK: Carrageenan induces interleukin-8 production
through distinct Bcl10 pathway in normal human colonic epithelial
cells. Am J Physiol Gastrointest Liver Physiol. 292:G829–G838.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bhattacharyya S, Borthakur A, Dudeja PK
and Tobacman JK: Carrageenan induces cell cycle arrest in human
intestinal epithelial cells in vitro. J Nutr. 138:469–475.
2008.PubMed/NCBI
|
|
20
|
Bhattacharyya S, Dudeja PK and Tobacman
JK: Carrageenan-induced NFkappaB activation depends on distinct
pathways mediated by reactive oxygen species and Hsp27 or by Bcl10.
Biochim Biophys Acta. 1780:973–982. 2008. View Article : Google Scholar
|
|
21
|
Bhattacharyya S, Gill R, Chen M, Zhang F,
Linhardt RJ, Dudeja PK and Tobacman JK: Toll-like receptor 4
mediates induction of the Bcl10-NFkappaB-interleukin-8 inflammatory
pathway by carrageenan in human intestinal epithelial cells. J Biol
Chem. 283:10550–10558. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bhattacharyya S, Dudeja PK and Tobacman
JK: Tumor necrosis factor alpha-induced inflammation is increased
but apoptosis is inhibited by common food additive carrageenan. J
Biol Chem. 285:39511–39522. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tanoue T, Nishitani Y, Kanazawa K,
Hashimoto T and Mizuno M: In vitro model to estimate gut
inflammation using co-cultured Caco-2 and RAW264.7 cells. Biochem
Biophys Res Commun. 374:565–569. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bhattacharyya S, Borthakur A, Pant N,
Dudeja PK and Tobacman JK: Bcl10 mediates LPS-induced activation of
NF-kappaB and IL-8 in human intestinal epithelial cells. Am J
Physiol Gastrointest Liver Physiol. 293:G429–G437. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schwabe RF and Brenner DA: Mechanisms of
liver injury. I. TNF-alpha-induced liver injury: role of IKK, JNK,
and ROS pathways. Am J Physiol Gastrointest Liver Physiol.
290:G583–G589. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gaur U and Aggarwal BB: Regulation of
proliferation, survival and apoptosis by members of the TNF
superfamily. Biochem Pharmacol. 66:1403–1408. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ogata M, Matsui T, Kita T and Shigematsu
A: Carrageenan primes leukocytes to enhance
lipopolysaccharide-induced tumor necrosis factor alpha production.
Infect Immun. 67:3284–3289. 1999.
|
|
28
|
Fraczek M, Sanocka D, Kamieniczna M and
Kurpisz M: Proinflammatory cytokines as an intermediate factor
enhancing lipid sperm membrane peroxidation in in vitro conditions.
J Androl. 29:85–92. 2008. View Article : Google Scholar : PubMed/NCBI
|
